Table 1.

Frequent genomic alterations (>20% of cases) detected in 38 penile tumors evaluated by aCGH

Genomic regionStart (bp)End (bp)EventGenesFrequency (%)
3p26.3–p25.1993,74814,191,316Loss14326
3p24.3–p22.215,550,92737,778,461Loss10942
3p22.238,062,74538,411,982Loss926
3p22.2–p21.3238,941,95144,629,118Loss7434
3p21.1–p14.354,190,32457,080,457Loss1526
3p14.166,457,07570,311,198Loss2332
3p13–p11.172,491,52190,264,177Loss4434
3q12.3–q13.13104,132,986110,515,632Gain3429
3q13.13–q13.31111,130,268115,247,042Gain4634
3q13.31–q25.31116,240,263157,523,060Gain42842
3q25.31–q29157,878,836199,501,827Gain38242
5p13.331,077,74632,825,265Gain1326
5p15.3301,305,409Gain3326
8p23.3–p11.21043,175,310Loss44450
8q11.1–q11.2347,062,12155,033,387Gain2834
8q12.155,682,23956,316,934Gain226
8q12.1–q21.1356,967,22082,092,323Gain17234
8q21.2–q24.387,183,119146,274,826Gain46166
8q22.3101,799,120103,732,868Gain1661
9p21.321,905,40522,067,827Loss626
9p12–p11.242,014,06942,702,421Gain926
9q33.3–q34.11129,284,384130,899,653Gain7929
20p12.116,381,42517,709,418Gain926
21p11.110,013,26310,117,957Gain626
21p11.110,013,26310,117,957Loss626
Yp11.27,278,85810,143,912Loss1929
Yq11.21–q11.22113,924,90617,801,127Loss639
Yq11.222–q11.22319,700,03923,283,748Loss2839

Abbreviation: bp, base pairs.